Signature reversion of three disease‐associated gene signatures prioritizes cancer drug repurposing candidates
Article in FEBS Open Bio (March 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Article in FEBS Open Bio (March 2024)
Article in BMC Pharmacology and Toxicology (January 2024)
Article in Frontiers in Toxicology (June 2023)